160 related articles for article (PubMed ID: 28144276)
21. Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Balle A; Kriegel S; Kupka MS; Friese K
Acta Histochem; 2004; 106(3):245-52. PubMed ID: 15186931
[TBL] [Abstract][Full Text] [Related]
22. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
Maleeva A; Milkov V
Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
24. Loss of expression of the gene deleted in colon carcinoma (DCC) is closely related to histologic differentiation and lymph node metastasis in endometrial carcinoma.
Saegusa M; Hashimura M; Hara A; Okayasu I
Cancer; 1999 Jan; 85(2):453-64. PubMed ID: 10023715
[TBL] [Abstract][Full Text] [Related]
25. Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma.
Guo T; Li B; Gu C
J BUON; 2013; 18(2):465-70. PubMed ID: 23818363
[TBL] [Abstract][Full Text] [Related]
26. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
27. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
28. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
29. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I
Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091
[TBL] [Abstract][Full Text] [Related]
30. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
31. [Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues].
Liao QP; Wu C; Zheng H; Yu L
Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):752-5. PubMed ID: 16324249
[TBL] [Abstract][Full Text] [Related]
32. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.
van der Putten LJM; Visser NCM; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Garcia A; Mancebo G; Alameda F; Trovik J; Kopperud RK; Huvila J; Schrauwen S; Koskas M; Walker F; Weinberger V; Minar L; Jandakova E; Snijders MPLM; van den Berg-van Erp S; Matias-Guiu X; Salvesen HB; Werner HMJ; Amant F; Massuger LFAG; Pijnenborg JMA
Int J Gynecol Cancer; 2018 Mar; 28(3):514-523. PubMed ID: 29324536
[TBL] [Abstract][Full Text] [Related]
33. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.
Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Miyazaki K
Oncology; 2013; 84(3):166-73. PubMed ID: 23306391
[TBL] [Abstract][Full Text] [Related]
34. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
35. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
[TBL] [Abstract][Full Text] [Related]
36. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
[TBL] [Abstract][Full Text] [Related]
37. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma].
Itoh E
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):812-20. PubMed ID: 2196312
[TBL] [Abstract][Full Text] [Related]
38. Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria.
Pickartz H; Beckmann R; Fleige B; Düe W; Gerdes J; Stein H
Virchows Arch A Pathol Anat Histopathol; 1990; 417(2):163-71. PubMed ID: 2114696
[TBL] [Abstract][Full Text] [Related]
39. [Estrogen and progesterone receptors in endometrial carcinoma].
Guo Y; Dang Q
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
[TBL] [Abstract][Full Text] [Related]
40. Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors.
Ghabreau L; Roux JP; Frappart PO; Mathevet P; Patricot LM; Mokni M; Korbi S; Wang ZQ; Tong WM; Frappart L
Int J Cancer; 2004 Apr; 109(3):317-21. PubMed ID: 14961567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]